NEXGEL, Inc. has named veteran finance executive Ian Blackman as its new Chief Financial Officer. Blackman is tasked with finalizing the acquisition of regenerative biomaterial products from Celularity Inc.
- Ian Blackman joins NEXGEL as CFO
- Blackman previously led finance at McIntosh Group, Inc.
- Strategic focus on closing the Celularity Inc. asset acquisition
- NEXGEL operates in healthcare, beauty, and OTC markets
- Shares were trading at $0.63 at the time of the announcement
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.